Business Context and Reporting Period
This Form 8-K filing by WEX Inc. (WEX) is dated October 12, 2020, and reports on a significant legal development regarding a proposed acquisition. On January 24, 2020, WEX entered into a Share Purchase Agreement to acquire eNett International (Jersey) Limited and Optal Limited (the "Sellers"). WEX subsequently notified the Sellers on May 4, 2020, that it would not close the transaction due to a Material Adverse Effect (MAE) caused by the COVID-19 pandemic. The Sellers initiated legal proceedings in the High Court of Justice of England and Wales on May 11, 2020, seeking specific performance of the agreement.
Key Financial Metrics
This filing is a Current Report on Form 8-K and does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity metrics. The document focuses exclusively on the status of the pending litigation and the interpretation of the MAE clause in the Purchase Agreement.
Material Changes and Legal Developments
On October 12, 2020, the London Court issued a judgment on preliminary issues following a trial held in late September 2020. Key findings include:
- Industry Definition: The Court ruled that eNett and Optal operate in the "business-to-business (B2B) payments industry," rejecting the Sellers' argument that they operate in a distinct "travel payments industry."
- MAE Comparison: The judgment establishes that the determination of whether the pandemic caused a disproportionate impact on the targets must be compared against other B2B payments companies, rather than the broader travel sector.
- Legal Interpretation: The Court addressed the burden of proof regarding the MAE clause and ruled on the applicability of carve-outs related to changes in law and reasonably expected events.
Outlook, Risks, and Management Commentary
WEX maintains its position that eNett and Optal have been disproportionately impacted by the pandemic compared to the B2B payments industry. However, the final determination of whether an MAE occurred will be decided at a subsequent trial, the outcome of which cannot be predicted.
Appeals: Both parties are seeking permission to appeal specific aspects of the judgment:
- Sellers: Seeking to appeal the definition of the relevant industry and the burden of proof.
- WEX: Seeking to appeal the Court's conclusion that impacts from changes in law arising from the pandemic cannot be considered in the MAE analysis, and the scope of the disproportionate effects carve-out.
Risks: The filing highlights risks including the uncertainty of the litigation outcome, the potential requirement to consummate the acquisition, financing risks, and unexpected costs associated with the legal proceedings.
Investor Verification Checklist
- Verify the status of the appeal process and any deadlines for the subsequent trial on the merits of the MAE claim.
- Monitor for any updates on the potential financial impact of the litigation, including legal fees and potential damages if WEX is forced to close the deal.
- Review WEX's most recent Form 10-Q or 10-K for baseline financial data, as this 8-K contains no operational metrics.
- Assess the strategic importance of the eNett and Optal acquisition to WEX's long-term growth plans in the event the deal is forced to close.